Bio

Tracy Marshbanks, with over two decades of experience at First Analysis, works with entrepreneurs as an investor and as an advisor on growth transactions to help build leading businesses where chemical and medical technologies are a key differentiating element. He is a thought leader in those areas, having authored widely read research papers. He supports First Analysis' investments in Checkpoint Surgical, CSA Medical, Current Ways, Medicinal Genomics, VIDA Diagnostics and Yunu. Prior to joining First Analysis in 1999, he held a number of positions with Amoco Corp. with responsibilities ranging from refining research and development to capital planning (first in petroleum refining and then in marketing). He earned an MBA from the University of Chicago, a doctorate in chemical engineering from Purdue University, and a bachelor's degree in chemical engineering from Colorado State University.